Vantage Consulting Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-322
Closed -$13K 1425
2020
Q4
$13K Buy
+322
New +$10.4K ﹤0.01% 1083

Other funds holding THC

Vantage Consulting Group's THC Position: Q1 2021 in Review

Vantage Consulting Group sold out of Tenet Healthcare (THC) in Q1 2021, closing a stake of 322 shares — an estimated $13K sold.

Vantage Consulting Group first reported a position in THC in Q4 2020 and held it in 1 quarter. The position peaked at $13K in Q4 2020. 309 funds tracked by Wall St. Rank hold THC as of Q1 2021.

  • Vantage Consulting Group reported no remaining Tenet Healthcare position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 322 Tenet Healthcare shares in Q1 2021, an estimated $13K.
  • Vantage Consulting Group first reported a position in Tenet Healthcare in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Tenet Healthcare position peaked at $13K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.